Technical Analysis for IMMX - Immix Biopharma, Inc.

Grade Last Price % Change Price Change
C 5.42 -4.24% -0.24
IMMX closed down 4.24 percent on Thursday, January 20, 2022, on 12 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical IMMX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Wide Bands Range Expansion -4.24%
Hot IPO Pullback Bullish Swing Setup -6.71%
Narrow Range Bar Range Contraction -6.71%
NR7 Range Contraction -6.71%
Hot IPO Pullback Bullish Swing Setup -7.19%
Outside Day Range Expansion -7.19%
Calm After Storm Range Contraction -4.07%
Older End-of-Day Signals for IMMX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 16 hours ago
Up 2% about 16 hours ago
60 Minute Opening Range Breakdown about 17 hours ago
Down 5% about 17 hours ago
Down 3% about 18 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. It is developing IMX-110 that is in Phase Ib/IIa clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. The company has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase Ib clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc. was incorporated in 2012 and is based in Los Angeles, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Autoimmune Disease Inflammation Colorectal Cancer Sarcoma Ulcerative Colitis Abdominal Pain Crohn's Disease Soft Tissue Sarcoma Beigene

Is IMMX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 8.6799
52 Week Low 2.85
Average Volume 13,199,673
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 4.72
10-Day Moving Average 5.85
Average True Range 1.01
ADX 0.0
+DI 32.92
-DI 12.18
Chandelier Exit (Long, 3 ATRs) 5.64
Chandelier Exit (Short, 3 ATRs) 5.89
Upper Bollinger Bands 7.29
Lower Bollinger Band 2.14
Percent B (%b) 0.64
BandWidth 109.27
MACD Line 0.74
MACD Signal Line 0.64
MACD Histogram 0.1034
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.17
Resistance 3 (R3) 6.23 6.04 6.05
Resistance 2 (R2) 6.04 5.85 6.01 6.00
Resistance 1 (R1) 5.73 5.73 5.64 5.67 5.96
Pivot Point 5.54 5.54 5.49 5.51 5.54
Support 1 (S1) 5.23 5.35 5.14 5.17 4.88
Support 2 (S2) 5.04 5.23 5.01 4.84
Support 3 (S3) 4.73 5.04 4.80
Support 4 (S4) 4.67